Back

Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Chronic Coronary Artery Disease: New Scientific Discoveries Inflammation and Immunity ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Norihito Takahashi

Juntendo University Graduate School of Medicine, Tokyo (Japan)

8 More presentations in this session

Presentation thumbnail
CCS patients with polyvascular disease are a high risk but heterogenous subset of patients: insights from the CLARIFY registry.
Doctor A. Gautier (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Size of low wall shear stress areas in coronary arteries is related to epicardial physiology and not to microcirculatory resistance
Doctor C. Wong (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Association of inflammatory disease and long-term outcomes among young adults with myocardial infarction: The Partners YOUNG-MI registry
Doctor B. Weber (Dallas, US)
Abstract Slides Video
Presentation thumbnail
Younger patients have an increased risk for dementia after coronary artery bypass grafting, a population-based cohort study from the SWEDEHEART registry.
Doctor S. Nielsen (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Doctor A. Argiro (Florence, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic Coronary Artery Disease: New Scientific Discoveries

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources